SPEAC: Study to Education Childhood Cancer Survivors About Survivorship Care

Sponsor
University of Illinois at Chicago (Other)
Overall Status
Completed
CT.gov ID
NCT01742481
Collaborator
(none)
50
1
2
27
1.8

Study Details

Study Description

Brief Summary

The proposed study is part of a career development award. The first two phases of research involve collaborating with adult survivors of childhood cancer representing both sexes and three ethnic/racial groups (African American, Hispanic, and White). THe collaboration will focus upon developing educational material that is helpful in teaching survivors about health risks related to cancer treatments and about survivorship care. The third phase is a randomized controlled trial that will randomly (like a flip of coin)place survivors into one of two groups. One group will meet in -person with a group leader three times, once each week over three weeks. The other group will receive an information packet that contains websites, books, and resources similar to content provided in-person within a group format to the other group. The goal is to help adult survivors get involved in specialized healthcare so they can remain healthy. This involves getting a copy of their medical record to understand what treatments they received and working with health providers to get an individualized survivorship care plan.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Education and empowerment
N/A

Detailed Description

The proposed study includes three aims: intervention development using focus groups, intervention refinement based upon a pre-pilot, and a randomized controlled pilot study of the final intervention. All participants are adult survivors of childhood cancer, males and females from three ethnic backgrounds (Black, Hispanic, White). The randomized control pilot is designed to assess the acceptibility/feasibility of a community-based intervention to engage childhood cancer survivors more actively in cancer follow-up care. Pilot data on outcome measures will provide data parameters (e.g. means and variances of groups) for accurate power analyses and sample size calculation to support a subsequent efficacy trial.

Relevance: This project is a critical initial step towards addressing systemic problems in transition of care and has the potential to decrease morbidity of adult childhood cancer survivors.

Outcomes include: knowledge of late effects and follow-up care, uncertainty related to 1) relapse, 2) secondary cancers, and 3) late effects, perceived efficacy to communicate with physician, access to childhood medical records, self-efficacy to obtain medical records, and the number of completed health care visits at a six month follow-up interview.

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Childhood Cancer Survivor Program to Empower Action in Care
Study Start Date :
Aug 1, 2010
Actual Primary Completion Date :
Mar 1, 2011
Actual Study Completion Date :
Nov 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Education and empowerment program

Three group sessions delivered once per week over three weeks. Education on late effects of treatment, survivorship care, how to request medical records, and role playing on how to talk to a provider about childhood cancer health risks

Behavioral: Education and empowerment
Three group sessions delivered once per week over three weeks. Education on late effects of treatment, survivorship care, how to request medical records, and role playing on how to talk to a provider about childhood cancer health risks

Placebo Comparator: self-guided empowerment and education

participants have information packet but receive no individualized support or assistance

Behavioral: Education and empowerment
Three group sessions delivered once per week over three weeks. Education on late effects of treatment, survivorship care, how to request medical records, and role playing on how to talk to a provider about childhood cancer health risks

Outcome Measures

Primary Outcome Measures

  1. scheduling a survivorship visit [6 months]

    Patient report of setting up an appointment at one of the three long-term follow-up clinics in Chicago or setting up an appointment with a physician who is working on a survivorship plan with the patient.

Secondary Outcome Measures

  1. requesting and obtaining medical records from pediatric oncology [6 months]

    Filling out a medical record request form and submitting the form to the pediatric oncology hospital. This may be done by the survivor or the physician.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosed with any childhood cancer excluding CNS prior to age of 18 years

  • Completed treatment at least 5 years ago

  • Currently cancer free and 18 years or older

  • Self-identifies as African American, Hispanic/Latino, or White

Exclusion Criteria:
  • Ever seen for risk-based follow-up care as an adult (18 or older)

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Illinois at Chicago Chicago Illinois United States 60608

Sponsors and Collaborators

  • University of Illinois at Chicago

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Lisa Sharp, Principal Investigator, University of Illinois at Chicago
ClinicalTrials.gov Identifier:
NCT01742481
Other Study ID Numbers:
  • K23CA124451
First Posted:
Dec 5, 2012
Last Update Posted:
May 11, 2016
Last Verified:
May 1, 2016
Keywords provided by Dr. Lisa Sharp, Principal Investigator, University of Illinois at Chicago

Study Results

No Results Posted as of May 11, 2016